Group 1 - Shenzhen has reached a milestone with over 600 listed companies, including 426 domestic and 174 overseas, with a total market capitalization exceeding 19 trillion yuan as of January 2026 [1] - The history of Shenzhen's listed companies reflects the evolution of China's modern corporate system, starting from the first stock issued in Bao'an in 1983 [2] - The establishment of the SME Board in 2004 and the Growth Enterprise Market in 2009 opened capital channels for private technology enterprises, with Shenzhen companies occupying significant positions [3] Group 2 - Recent years have seen a new wave of companies redefining "Shenzhen speed," with notable listings such as Yuntian Lifei and Youbixuan, showcasing rapid growth and innovation [4] - New companies listed on the Science and Technology Innovation Board and the Growth Enterprise Market indicate Shenzhen's proactive embrace of capital market reforms and alignment with cutting-edge technology [5] - In the first three quarters of 2025, Shenzhen-listed companies achieved a total revenue of 5.20 trillion yuan and a net profit of 457.8 billion yuan, reflecting strong growth in the manufacturing sector [7] Group 3 - The Hong Kong market has seen significant activity, with 27 new companies raising a total of 29.57 billion HKD, and over 70% of these companies experiencing stock price increases on their first trading day [7] - The strong performance of companies like BYD, which raised over 43.5 billion HKD in a single refinancing, highlights the robust capital market environment in Shenzhen [7] - Shenzhen's high-tech exports, including drones and 3D printers, grew by 10.1% in 2025, supported by a solid foundation of national high-tech enterprises [7] Group 4 - The journey from the first stock in 1983 to 600 listed companies today illustrates Shenzhen's transformation from a pilot city to a benchmark for capital markets in China [8] - Each listed company represents a milestone for Shenzhen, indicating that reaching 600 is not an endpoint but a new starting point for further growth [8]

Core Insights - The Shenzhen listed companies have contributed over 2 trillion yuan in taxes in the past five years and more than 3.5 trillion yuan in the last decade, supporting regional employment with over 4 million jobs [1][2] - During the 14th Five-Year Plan period, Shenzhen listed companies distributed nearly 990 billion yuan in dividends, significantly exceeding the equity financing scale, ranking second among major cities in China [1] - In 2025, the cash dividends are expected to exceed 180 billion yuan, with leading companies like China Ping An and China Merchants Bank maintaining over 10 years of continuous dividends [1] Financial Performance - In the first three quarters of 2025, 52 listed companies in Shenzhen paid out 50.201 billion yuan in cash dividends, setting a new record with a payout ratio exceeding 30% [1] - The stock prices of major companies have shown strong performance, with China Ping An's stock price increasing by 35.87%, China Merchants Bank's A-shares rising by 11.76%, and Industrial Fulian's stock price surging by 194.26% [1] Economic Impact - In the first three quarters of 2025, Shenzhen listed companies paid nearly 285 billion yuan in various taxes and provided over 4 million jobs, with total employee compensation exceeding 620 billion yuan and an average annual salary of over 200,000 yuan [2] - Leading enterprises are showing strong investment intentions, significantly increasing their investments in fixed assets and other long-term assets, which injects sustainable momentum into economic development [2] - Innovative companies like UBTECH and Huichuan Technology are not only creating numerous high-end job opportunities but also driving the development of thousands of small and medium-sized enterprises in the supply chain, fostering a robust ecosystem [2]

Core Viewpoint - The insurance capital is actively increasing its stakes in undervalued insurance stocks, indicating a strategic shift towards long-term stable returns and improved investment yields [1][4][5]. Group 1: Investment Activities - On February 10, Ping An Life announced that it had acquired 10% of China Life's H-shares, triggering a mandatory disclosure under Hong Kong regulations [1]. - Ping An Life previously reached a 5% stake in China Life's H-shares on August 12, 2025, and has since continued to increase its holdings, including significant purchases of 12.68 million shares and 44.09 million shares in late August 2025 [4]. - In addition to China Life, Ping An Life has also increased its stake in China Pacific Insurance, raising its ownership from 4.98% to 5.04% through a purchase of 174.14 million shares at an average price of HKD 32.0655 per share [4]. Group 2: Market Trends and Insights - Analysts suggest that the trend of insurance capital acquiring undervalued stocks is driven by the need for stable dividend yields and the desire to match assets with liabilities effectively [5][6]. - The investment strategy of Ping An emphasizes a "three criteria" principle: reliable operations, expected growth, and sustainable dividends, which guides their long-term investment decisions [5]. - The demand for insurance capital to acquire stocks is expected to continue into 2026, with a focus on both high dividend yield and high return on equity (ROE) targets [6][7].

香港本地股方面，长实集团涨0.77%，收报47.18港元；新鸿基地产涨2.85%，收报133.5港元；恒基 地产跌0.67%，收报32.74港元。 中资金融股方面，中国银行无升跌，收报4.72港元；建设银行跌0.86%，收报8.08港元；工商银行 跌0.91%，收报6.5港元；中国平安跌0.83%，收报71.9港元；中国人寿涨0.64%，收报34.34港元。 石油石化股方面，中国石油化工股份涨2.72%，收报5.66港元；中国石油股份涨0.85%，收报9.46港 元；中国海洋石油涨1.29%，收报25.12港元。 新华社香港2月12日电 香港恒生指数12日跌233.84点，跌幅0.86%，收报27032.54点。全日主板成交 2387.05亿港元。 国企指数跌93.0点，收报9175.18点，跌幅1.0%。恒生科技指数跌91.01点，收报5408.98点，跌幅 1.65%。 蓝筹股方面，腾讯控股跌2.28%，收报535.5港元；香港交易所跌0.96%，收报414港元；中国移动跌 0.32%，收报78.2港元；汇丰控股跌0.21%，收报139.5港元。 ...

这是无数中国肿瘤患者求医路上的缩影。而一场正在席卷全球的医疗AI变革，正在试图驱散这层"信息 决策盲区"。 2026年1月，医疗AI初创公司OpenEvidence宣布完成D轮融资，估值飙升至120亿美元。这家成立仅几年 的公司，凭借一款能实时检索权威文献，基本做到"零幻觉"的AI工具，让全美超过40%的执业医生都在 使用。 有的专家可能建议一种听起来极具科技感的方案，"手术+海外细胞疗法"，费用高达100万元，且完全在 医保报销范围之外；而另一套则是基于临床指南的"标准方案"，手术叠加放化疗与内分泌治疗，费用约 为15万元。 面对厚达几十页、充斥着晦涩术语的各种检查报告，患者不仅面临着"治病"的焦虑，更面临着"致贫"的 现实风险。 深耕重疾诊疗全流程，做难而正确的事。 对于一位刚确诊为乳腺癌的患者来说，摆在她面前的，除了是医学诊疗的复杂性，还有医疗支出的不确 定性。 这股热浪迅速传导至中国。互联网大厂们纷纷跟进，以各自擅长点切入，希望成为中国的 OpenEvidence。当大厂们还在比拼谁更会聊天更会找文献时，中国平安并没有止步于做一个"好用的AI 问答工具"。而是依托在金融与大健康领域的多年深耕，中国平台 ...

有的专家可能建议一种听起来极具科技感的方案， " 手术+海外细胞疗法" ，费用高达100万元，且完全在医保报销范围之外；而另一套则是基于临床指南 的 " 标准方案" ，手术叠加放化疗与内分泌治疗，费用约为15万元。 深耕重疾诊疗全流程，做难而正确的事。 对于一位刚确诊为乳腺癌的患者来说，摆在她面前的，除了是医学诊疗的复杂性，还有医疗支出的不确定性。 这是无数中国肿瘤患者求医路上的缩影。而一场正在席卷全球的医疗AI变革，正在试图驱散这层 " 信息决策盲区" 。 2026年1月，医疗AI初创公司OpenEvidence宣布完成D轮融资，估值飙升至120亿美元。这家成立仅几年的公司，凭借一款能实时检索权威文献，基本做到 " 零幻觉" 的AI工具，让全美超过40%的执业医生都在使用。 这股热浪迅速传导至中国。互联网大厂们纷纷跟进，以各自擅长点切入，希望成为中国的OpenEvidence。当大厂们还在比拼谁更会聊天更会找文献时，中 国平安并没有止步于做一个 " 好用的AI问答工具" 。而是依托在金融与大健康领域的多年深耕，中国平台正在极力构建一个集 " 深度诊疗" 与 " 风控大脑" 于一体的AI-MDT（多学科会诊） ...

新华财经上海2月12日电 中国经济信息社上海总部行业洞察产业数据服务平台（以下简称"行业洞察"） 12日发布2025年中国大数据产业城市竞争力TOP50榜单显示，北京（93.25）、上海（92.18）、深圳 （91.56）位列榜单前三位。 2025年我国大数据产业规模持续扩大，增长得益于国家顶层设计推动和企业数字化转型需求的全面释 放。各地依托区域优势积极推动大数据产业发展，目前国内已经形成京津冀、长三角、粤港澳大湾区三 大核心产业集群。在应用层面，大数据已深度渗透千行百业，创造显著价值。 2025年北京市位列中国大数据产业城市竞争力TOP50榜单首位，北京大数据产业在国家战略引领和"全 球数字经济标杆城市"建设目标驱动下，呈现出规模领先、技术前沿、政策创新、区域协同的鲜明特 征，已成为首都经济高质量发展的核心引擎。 近年来北京率先建设"国家数据要素综合试验区"，坚持"以用为先"，持续开放城市级应用场景，推动大 数据从技术走向价值转化。榜单显示，2025年，北京大数据产业在产业规模（92.18)、优质企业 （96.53)、创新能力（92.21)、融资能力（92.62)、成长能力（90.11)等方面均表现突出。 ...

Core Viewpoint - The article discusses the selection process for agricultural insurance companies in China, emphasizing that while farmers have the right to choose, their options are limited to designated companies within their region [1][3]. Group 1: Agricultural Insurance Selection Process - Farmers can choose insurance providers, but they are typically restricted to those selected through a competitive bidding process by local governments [1][3]. - In regions like Heilongjiang, a list of qualified insurance companies for the period from January 1, 2024, to December 31, 2026, includes several major firms such as PICC Property and Casualty, Sunshine Agricultural Mutual Insurance, and others [2]. Group 2: Rationale Behind the Selection Process - The selection process aims to maintain a balance between adequate competition and service quality, as agricultural insurance relies heavily on local service networks [3][4]. - A stable relationship with selected insurance companies encourages long-term investment in disaster prevention and loss reduction infrastructure, which is crucial for effective agricultural insurance [3][4]. - The process allows for competition during the qualification phase, where companies must demonstrate their capital strength and service capabilities, followed by performance evaluations during the operational period [4].

Core Insights - The healthcare payment system in China is transitioning from a "basic medical insurance" model to a "basic medical insurance + commercial insurance" multi-collaboration model, creating new growth momentum in the healthcare service sector and increasing demand for professional commercial insurance services [2][3] - The rapid expansion of the innovative pharmaceutical and medical device market, projected to grow from RMB 92.3 billion in 2019 to RMB 162 billion by 2024, with a compound annual growth rate (CAGR) of 11.9%, is driving the healthcare service sector [2] - The commercial health insurance market is expected to reach RMB 23,568 billion by 2030, with a CAGR of 15.8% from 2024 to 2030, indicating significant growth potential [2] Industry Dynamics - The dual-track growth of the healthcare payment system highlights the challenges in industry chain collaboration, with insurance companies facing constraints in talent and data, while innovative pharmaceutical companies encounter value realization bottlenecks [3] - Commercial insurance service providers are positioned as key players to address these challenges, facilitating collaboration across the industry chain [3] Key Players and Strategies - Major insurance companies like Ping An and China Pacific Insurance are enhancing their service offerings by building health management systems to improve the attractiveness and service experience of commercial insurance products [4] - Internet giants such as Ant Group leverage their large user base and technological advantages to innovate in direct payment models and digital empowerment, aiming to lower barriers for users in insurance participation and claims [4] - Specialized platform companies like Meixin Health focus on resource integration and technological empowerment, utilizing AI risk control and data platforms to connect pharmaceutical companies, insurers, and patients [5] Meixin Health's Performance - Meixin Health, as the largest multi-payment platform in China, has demonstrated a differentiated competitive advantage through its asset-light model, achieving revenue growth from RMB 1.069 billion in 2022 to RMB 2.035 billion in 2024, effectively doubling its revenue [6] - The adjusted net loss for Meixin Health has significantly narrowed from RMB 447 million to RMB 80 million, indicating a strong trend towards profitability [6] - In the first ten months of 2025, Meixin Health reported revenue of RMB 1.873 billion, a 34% year-on-year increase, with an adjusted net loss of RMB 55 million, continuing the trend of improving financial performance [6] Future Outlook - The healthcare payment sector is entering a new development cycle characterized by policy benefits, data assets, and product iteration, with commercial insurance service providers expected to see exponential growth in value as the payment ecosystem matures [7] - Meixin Health is well-positioned to solidify its market position through its business layout, platform-based operational model, technological advantages, and robust financial performance [7]

来源：中国金融家杂志 平安养老保险股份有限公 司党委书记、董事长 甘为民 灵蛇辞岁去，骏马迎春来。在这个辞旧迎新的重要时刻，我谨代表平安养老保险股份有限公司，向《中 国金融家》杂志的广大读者们，向长期在养老金融事业默默耕耘的同仁们，向长期关心支持平安养老险 的朋友们，致以最诚挚的祝福，祝愿大家新春快乐、阖家幸福！ 新春畅想 责任编辑：曹睿潼 来源：中国金融家杂志 2026年是"十五五"开局之年，是中国共产党建党105周年，也是落实积极应对人口老龄化国家战略和加 快建设金融强国的重要一年。作为养老金融行业的一员，我们既是这些伟大事业的见证者，更是参与 者、建设者。在这一重要历史节点，我们将以高度的责任感和使命感，助力国家加快建设应对人口老龄 化的养老金融体系。 锚定"十五五"，勇担新使命。作为第一家冠以"养老"字样的持牌金融机构，平安养老险目前管理的年金 资产规模已超万亿元。20多年来，我们深知使命光荣、责任重大，认识到年金既是老百姓的"养老钱"， 也是国家养老保险体系的重要支柱。"十五五"期间，我们将继续深耕养老主业，贯彻国家对保险资金、 年金基金等中长期资金入市的要求，强化数字化转型，优化投资策略，为老百姓 ...